Long-term stability of diluted solutions of the monoclonal antibody rituximab
Authors:
- Muriel PaulMPMuriel Paul
- Victoire VieillardVVVictoire Vieillard
- Emmanuel JaccouletEJEmmanuel Jaccoulet
- Alain AstierAAAlain Astier
- 1 October 2012
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 436 (1-2) , 282-290
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Guidelines for the practical stability studies of anticancer drugs: A European consensus conferenceAnnales Pharmaceutiques Françaises, 2011
- Peptide mapping of therapeutic monoclonal antibodies: Improvements for increased speed and fewer artifactsJournal of Chromatography B, 2009
- Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibodyJournal of Chromatography B, 2007
- Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care OntarioCancer Treatment Reviews, 2007
- SIX-MONTH STABILITY OF BEVACIZUMAB (AVASTIN) BINDING TO VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER WITHDRAWAL INTO A SYRINGE AND REFRIGERATION OR FREEZINGRetina, 2006
- Non-enzymatic hinge region fragmentation of antibodies in solutionJournal of Chromatography B, 2005
- Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein AggregationPharmaceutical Research, 2003
- Spectroscopic Study of Secondary Structure and Thermal Denaturation of Recombinant Human Factor XIII in Aqueous SolutionArchives of Biochemistry and Biophysics, 1997
- Effect of Glass Transition Temperature on the Stability of Lyophilized Formulations Containing a Chimeric Therapeutic Monoclonal AntibodyPharmaceutical Research, 1997
- Second-derivative spectroscopy of proteins: Studies on tyrosyl residuesAnalytical Biochemistry, 1980